This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
CTI BioPharma Corp.
CTIC : NASDAQ :
$2.36 0.15 | 6.79%
Today's Range: 2.24 - 2.37
Avg. Daily Volume: 0
12/17/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CTIC CTI BIOPHARMA CORP 2.38 378.63 n/m 75.17 4090.18
OSIR OSIRIS THERAPEUTICS INC 12.96 444.79 n/a 48.63 153.75
ONVO ORGANOVO HOLDINGS INC 5.50 442.78 n/m 0.40 -57.87
ZIOP ZIOPHARM ONCOLOGY INC 4.26 437.55 n/m 1.23 54.12
IMMU IMMUNOMEDICS INC 4.67 434.93 n/m 4.62 -50.95
DVAX DYNAVAX TECHNOLOGIES CORP 15.20 399.70 n/m 11.60 13.63
IDRA IDERA PHARMACEUTICALS INC 3.87 332.09 n/m 0.08 38.88
ARWR ARROWHEAD RESEARCH CORP 5.93 324.27 n/m 0.18 -39.66
TKMR TEKMIRA PHARMACEUTICALS CORP 14.09 314.40 n/m 18.12 50.33
PPHM PEREGRINE PHARMACEUTICLS INC 1.49 289.20 n/m 22.16 -5.06
EXEL EXELIXIS INC 1.40 273.30 n/m 22.11 -36.49
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CTIC Ind Avg S&P 500
n/m 66.62 19.74
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs